Geftiglan 250mg Tablet

Introduction to Geftiglan 250mg Tablet

Geftiglan 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients whose cancer has certain genetic mutations called EGFR mutations. This tablet is often prescribed to patients who have not undergone chemotherapy before.

Composition of Geftiglan 250mg Tablet

The active ingredient in Geftiglan 250mg Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it works by blocking signals that promote cancer cell growth, specifically targeting the mutated EGFR receptors.

Uses of Geftiglan 250mg Tablet

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Effective for patients with specific EGFR gene mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Geftiglan 250mg Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geftiglan 250mg Tablet

Geftiglan 250mg Tablet should not be taken by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Geftiglan 250mg Tablet

• Take one tablet orally once daily.
• Consume the tablet at the same time each day for consistency.
• Follow your healthcare provider's instructions carefully.

Conclusion of Geftiglan 250mg Tablet

Geftiglan 250mg Tablet is a targeted therapy for non-small cell lung cancer with specific genetic mutations. While it offers significant benefits, it is essential to be aware of its side effects and take necessary precautions. Always consult with your healthcare provider to ensure it is the right treatment for you.